Circulation Research, Vol 73, 857-868, Copyright © 1993 by American Heart Association

ARTICLES

Use-dependent block and use-dependent unblock of the delayed rectifier K+ current by almokalant in rabbit ventricular myocytes

E Carmeliet
Laboratory of Physiology, University of Leuven, Belgium.

A voltage-clamp analysis of the effect of almokalant on the delayed rectifier K+ current (IK) was made in rabbit ventricular myocytes. The two-suction pipette method was used, and appropriate voltage-clamp protocols were used to study more specifically use dependence, block development, and recovery from block. Almokalant interacted with the IK in two ways: it shifted the activation curve in the hyperpolarizing direction (stimulatory effect) and blocked the open IK channel in a use- dependent way (inhibitory effect). For 2-second voltage clamps to +20 mV, half-maximum block was obtained at 5 x 10(-8) mol/L, with a Hill coefficient of 1.76. Use-dependent block was related to an open-channel block that occurred at 0 mV with a time constant of 1.07 second and a rather slow recovery from block: at -50 mV, recovery time constant was approximately 10 seconds; at -75 mV, recovery was practically absent. The absence of an important recovery at negative membrane potentials is consistent with the hypothesis of the drug being trapped in the channel. A limited frequency-dependent block could be demonstrated. Use- dependent unblock was demonstrated by a rapid recovery from block during stimulation following complete washout of the drug. It is concluded that almokalant shifts the activation curve of IK in the hyperpolarizing direction, blocks the open channel, and is trapped by the closure of the activation gate.

This article has been cited by other articles:

				M. Perry, M. J. de Groot, R. Helliwell, D. Leishman, M. Tristani-Firouzi, M. C. Sanguinetti, and J. Mitcheson Structural Determinants of HERG Channel Block by Clofilium and Ibutilide Mol. Pharmacol., August 1, 2004; 66(2): 240 - 249. [Abstract] [Full Text] [PDF]

				C. Antzelevitch, L. Belardinelli, L. Wu, H. Fraser, A. C. Zygmunt, A. Burashnikov, J. M. Di Diego, J. M. Fish, J. M. Cordeiro, R. J. Goodrow Jr, et al. Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal Agent Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S65 - S83. [Abstract] [PDF]

				M. B. Thomsen, P. G. A. Volders, M. Stengl, R. L. H. M. G. Spaatjens, J. D. M. Beekman, U. Bischoff, M. A. Kall, K. Frederiksen, J. Matz, and M. A. Vos Electrophysiological Safety of Sertindole in Dogs with Normal and Remodeled Hearts J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 776 - 784. [Abstract] [Full Text] [PDF]

				X.-K. Liu, A. Katchman, B. H Whitfield, G. Wan, E. M Janowski, R. L Woosley, and S. N Ebert In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits Cardiovasc Res, January 1, 2003; 57(1): 28 - 36. [Abstract] [Full Text] [PDF]

				M. Weerapura, S. Nattel, D. Chartier, R. Caballero, and T. E Hebert A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link? J. Physiol., April 1, 2002; 540(1): 15 - 27. [Abstract] [Full Text] [PDF]

				M. M. Rahme, G. Ungab, M. Wadhwa, F. Al-Kandari, B. Yao, A. Gupta, K. Lee, H.-Y. Kim, and G. K. Feld Electrophysiologic and Antiarrhythmic Effects of the New Class III Antiarrhythmic Drug KCB-328 in Experimental Canine Atrial Flutter Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2001; 6(3): 297 - 306. [Abstract] [PDF]

				K. Kamiya, J. S. Mitcheson, K. Yasui, I. Kodama, and M. C. Sanguinetti Open Channel Block of HERG K+ Channels by Vesnarinone Mol. Pharmacol., August 1, 2001; 60(2): 244 - 253. [Abstract] [Full Text] [PDF]

				L. M Hondeghem, K. Dujardin, and F. De Clerck Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmia Cardiovasc Res, May 1, 2001; 50(2): 345 - 353. [Abstract] [Full Text] [PDF]

				L. M. Hondeghem, L. Carlsson, and G. Duker Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic Circulation, April 17, 2001; 103(15): 2004 - 2013. [Abstract] [Full Text] [PDF]

				R. Caballero, E. Delpón, C. Valenzuela, M. Longobardo, T. González, and J. Tamargo Direct Effects of Candesartan and Eprosartan on Human Cloned Potassium Channels Involved in Cardiac Repolarization Mol. Pharmacol., April 1, 2001; 59(4): 825 - 836. [Abstract] [Full Text]

				S. C. Verduyn, J. M. v. Opstal, J. D. Leunissen, and M. A. Vos Assessment of the Pro-Arrhythmic Potential of Anti-Arrhythmic Drugs: An Experimental Approach Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2001; 6(1): 89 - 97. [PDF]

				G. J Amos, C. Abrahamsson, G. Duker, L. Hondeghem, M. Palmer, and L. Carlsson Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential Cardiovasc Res, February 1, 2001; 49(2): 351 - 360. [Abstract] [Full Text] [PDF]

				B. D Walker, C. B Singleton, H. Tie, J. A Bursill, K. R Wyse, S. M Valenzuela, S. N Breit, and T. J Campbell Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channel Cardiovasc Res, October 1, 2000; 48(1): 44 - 58. [Abstract] [Full Text] [PDF]

				J C Hancox, K C R Patel, and J V Jones Antiarrhythmics---from cell to clinic: past, present, and future Heart, July 1, 2000; 84(1): 14 - 24. [Full Text] [PDF]

				M. Jiang, W. Dun, J.-S. Fan, and G.-N. Tseng Use-Dependent `Agonist' Effect of Azimilide on the HERG Channel J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1324 - 1336. [Abstract] [Full Text]

				D. M Roden and J. R Balser A plethora of mechanisms in the HERG-related long QT syndrome: Genetics meets electrophysiology Cardiovasc Res, November 1, 1999; 44(2): 242 - 246. [Full Text] [PDF]

				E. Delpon, R. Caballero, C. Valenzuela, M. Longobardo, D. Snyders, and J. Tamargo Benzocaine enhances and inhibits the K+ current through a human cardiac cloned channel (Kv1.5) Cardiovasc Res, May 1, 1999; 42(2): 510 - 520. [Abstract] [Full Text] [PDF]

				P. G. A. Volders, K. R. Sipido, E. Carmeliet, R. L. H. M. G. Spatjens, H. J. J. Wellens, and M. A. Vos Repolarizing K+ Currents ITO1 and IKs Are Larger in Right Than Left Canine Ventricular Midmyocardium Circulation, January 19, 1999; 99(2): 206 - 210. [Abstract] [Full Text] [PDF]

				P. G. A. Volders, K. R. Sipido, M. A. Vos, A. Kulcsar, S. C. Verduyn, and H. J. J. Wellens Cellular Basis of Biventricular Hypertrophy and Arrhythmogenesis in Dogs With Chronic Complete Atrioventricular Block and Acquired Torsade de Pointes Circulation, September 15, 1998; 98(11): 1136 - 1147. [Abstract] [Full Text] [PDF]

				A. M. Gillis, R. A. Geonzon, H. J. Mathison, E. Kulisz, W. M. Lester, and H. J. Duff The Effects of Barium, Dofetilide and 4-Aminopyridine (4-AP) on Ventricular Repolarization in Normal and Hypertrophied Rabbit Heart J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 262 - 270. [Abstract] [Full Text]

				S. Nattel Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs Cardiovasc Res, March 1, 1998; 37(3): 567 - 577. [Abstract] [Full Text] [PDF]

				J. Toyama, K. Kamiya, J. Cheng, J.-K. Lee, R. Suzuki, and I. Kodama Vesnarinone Prolongs Action Potential Duration Without Reverse Frequency Dependence in Rabbit Ventricular Muscle by Blocking the Delayed Rectifier K+ Current Circulation, November 18, 1997; 96(10): 3696 - 3703. [Abstract] [Full Text]

				M. V. Brahmajothi, M. J. Morales, K. A. Reimer, and H. C. Strauss Regional Localization of ERG, the Channel Protein Responsible for the Rapid Component of the Delayed Rectifier, K+ Current in the Ferret Heart Circ. Res., July 19, 1997; 81(1): 128 - 135. [Abstract] [Full Text]

				M. Holmgren, P. L. Smith, and G. Yellen Trapping of Organic Blockers by Closing of Voltage-dependent K+ Channels: Evidence for a Trap Door Mechanism of Activation Gating J. Gen. Physiol., May 1, 1997; 109(5): 527 - 535. [Abstract] [Full Text] [PDF]

				M. Nemeth, A. Varro, L. Virag, O. Hala, D. Thormahlen, and J. Gyula Papp Frequency-dependent Cardiac Electrophysiologic Effects of Tedisamil: Comparison With Quinidine and Sotalol Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(4): 273 - 284. [Abstract] [PDF]

				P. S. Spector, M. E. Curran, M. T. Keating, and M. C. Sanguinetti Class III Antiarrhythmic Drugs Block HERG, a Human Cardiac Delayed Rectifier K+ Channel : Open-Channel Block by Methanesulfonanilides Circ. Res., March 1, 1996; 78(3): 499 - 503. [Abstract] [Full Text]

				E. Delpon, C. Valenzuela, O. Perez, O. Casis, and J. Tamargo Propafenone Preferentially Blocks the Rapidly Activating Component of Delayed Rectifier K+ Current in Guinea Pig Ventricular Myocytes : Voltage-Independent and Time-Dependent Block of the Slowly Activating Component Circ. Res., February 1, 1995; 76(2): 223 - 235. [Abstract] [Full Text]

				M. Weerapura, S. Nattel, D. Chartier, R. Caballero, and T. E Hebert A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link? J. Physiol., April 1, 2002; 540(1): 15 - 27. [Abstract] [Full Text] [PDF]